arBtrage CAPITALIZING MARKETS checking… Sign in

Cardiff Oncology, Inc.

CRDF Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.50
▼ -3.2% Today
as of Jun 7, 07:12 ET
Last 30 days -10.71% Apr 28 → Jun 05
$1.36 $1.51 $1.67 $1.83 $1.98 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$1.51
High
$1.60
Low
$1.40
Volume
$3M
Avg Vol
$1M
Mkt Cap
$126M
P/E (TTM)
Beta
52w High
$4.56
52w Low
$1.35
Div Yield
Shares Out
$68M

Overview

52-week range
$1.35
$4.56
5% of range
Avg surprise (last 2)
-21.9%
Avg reaction (last 2)
+4.0%
100% positive
Latest IV / EM
337%
EM ±46.7% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.26$-0.23$-0.20$-0.16$-0.13 Actual $-0.25Actual $-0.22Actual $-0.22Actual $-0.26Actual $-0.25Actual $-0.20Est $-0.19Actual $-0.21Actual $-0.17Actual $-0.18Est $-0.13 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-14M$-13M$-13M$-12M$-12M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-0.18 $-0.13 -38.5% +10.0% +2.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.17 financials
Mon Jun 30, 2025Jun 2025 $-0.21 financials
Thu May 8, 2025Mar/2025 $-0.20 $-0.19 -5.3% +5.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.25 financials
Sun Jun 30, 2024Jun 2024 $-0.26 financials
Sun Mar 31, 2024Mar 2024 $-0.22 financials
Sat Sep 30, 2023Sep 2023 $-0.22 financials
Fri Jun 30, 2023Jun 2023 $-0.25 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-13M$-12M$-15M$-14M$-13M$-13M
Net income$-12M$-11M$-14M$-13M$-12M$-12M
EPS (diluted)$-0.18$-0.17$-0.21$-0.20$-0.25$-0.26

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$9M$17M$10M$11M$24M$51M$13M$26M
Inventory
Total current assets$47M$60M$62M$74M$83M$95M$59M$62M
Total assets$49M$62M$64M$76M$85M$97M$63M$66M
Long-term debt
Total liabilities$14M$16M$15M$17M$14M$14M$14M$14M
Total equity$35M$45M$49M$59M$71M$83M$49M$52M

Implied volatility — last 90 days

331%334%336%339%341% Jun 07 — IV 337% · EM ±46.7%

Sector peers